Investor presentation

RNS Number : 5664Q

Omega Diagnostics Group PLC

22 June 2020

 

OMEGA DIAGNOSTICS GROUP PLC

("Omega" or the "Company" or the "Group")

Investor presentation

Omega (AIM: ODX), the medical diagnostics company focused on CD4, food intolerance and COVID-19 testing, announces that a Company presentation delivered by Colin King, Chief Executive, and Kieron Harbinson, Group Finance Director, to update shareholders following the recent fundraising announcement, is now available to view on the Company's website: http://www.omegadiagnostics.com/Investor-Relations/Corporate-Information

No new price-sensitive information is disclosed as part of the presentation. Within the presentation the Company provides indicative guidance on timelines for product evaluations, product supply, potential timing for first commercial sales and targeted production volumes. These timelines are for guidance purposes only and there is no guarantee that these will be met. The Company expects to keep shareholders updated regularly on progress in achieving these future milestones.

Contacts: 

Omega Diagnostics Group PLC	Tel: [phone]
Bill Rhodes, Interim Non-Executive Chairman Colin King, Chief Executive	www.omegadiagnostics.com
Kieron Harbinson, Group Finance Director
finnCap Ltd	Tel: [phone]
Geoff Nash/Hannah Boros (Corporate Finance)
Camille Gochez (ECM)
Walbrook PR Limited	Tel: [phone] or [e-mail]
Paul McManus	Mob: [phone]
Lianne Cawthorne	Mob: [phone]

 

END

 

 

NRAUKONRRVUNAAR